DYNE-101 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

CXMT is reportedly preparing a NAND flash research and development production line in Beijing as the newly listed Chinese memory-chip company expands beyond DRAM. Representative image.

CXMT targets NAND flash as $8.6bn IPO gives China’s memory champion room to expand

Morgan Stanley’s North Haven Private Income Fund is working through another oversubscribed repurchase offer as private-credit liquidity demand remains elevated. Representative image.

Morgan Stanley private credit fund again gets withdrawal requests above its 5% limit

OpenAI reportedly expects hundreds of billions of dollars of negative free cash flow as it finances massive computing and data-centre expansion through 2030. Representative image.

OpenAI’s reported $278bn cash burn reveals the financing scale behind frontier AI

Taboola.com Ltd. has agreed to acquire finance-focused advertising technology company Dianomi plc for £19 million in guaranteed cash consideration and up to £27 million including contingent payments. Representative image.

Taboola offers up to £27m for Dianomi as AI reshapes digital advertising

Dyne Therapeutics stock faces dilution pressure after the biotechnology company priced its upsized $375 million public offering at $20.50 per share to support clinical development and potential drug launches. Representative image.

Read More

Pharma Industry News

Dyne Therapeutics (NASDAQ: DYN) slides as $375m stock sale resets valuation

Dyne Therapeutics strengthens launch funding, but its discounted $375 million share sale tests whether regulatory progress can outrun dilution pressure.

byPallavi Madhiraju

July 22, 2026

web analytics